Key Takeaways
- A randomized controlled trial found nattokinase reduced a key cardiovascular risk marker (von Willebrand factor) by 26% specifically in women — an effect not observed in men
- Japanese epidemiological studies show habitual natto intake is inversely associated with osteoporotic fracture risk in postmenopausal women, largely due to its vitamin K2 (MK-7) content
- Standard dosage across clinical trials is 2,000 FU (fibrinolytic units) daily, with blood pressure improvements typically appearing within 8 weeks
- Women on blood-thinning medications, hormonal contraceptives, or HRT should consult a healthcare provider before taking nattokinase due to potential interactions
- A 3-year trial demonstrated that MK-7 (the vitamin K2 form in natto) significantly suppressed bone loss in postmenopausal women, with protective effects emerging from year two
If you've been researching natural ways to support your cardiovascular health, you've probably come across nattokinase — a fibrinolytic enzyme derived from natto, the traditional Japanese fermented soybean food. But here's what most guides won't tell you: the vast majority of nattokinase content online treats women's health as an afterthought, lumping everyone into the same generic advice.
That matters because women face distinct cardiovascular and bone health challenges, particularly during and after menopause. Estrogen decline accelerates arterial stiffness, bone loss, and changes in clotting factors — all areas where nattokinase research is gaining traction. And when you add Japanese research into the picture, an entirely different dimension of evidence emerges, especially around bone health and functional food applications that international sources rarely cover.
Our team reviewed over 25 clinical studies, meta-analyses, and epidemiological reports — including Japanese-language research from J-STAGE and government databases — to build this guide. Here's what the evidence actually shows about nattokinase benefits for women, where it falls short, and what you should know before deciding if it's right for you.
What Is Nattokinase?
To understand the nattokinase benefits for women that research supports, it helps to start with what this enzyme actually is. Nattokinase is a serine protease enzyme produced by Bacillus subtilis natto during the fermentation of soybeans into natto — a traditional Japanese food consumed for over 1,000 years. The enzyme was first identified and named by Dr. Hiroyuki Sumi at Chicago University Medical School, who discovered its remarkable ability to dissolve blood clots.
How Nattokinase Works in the Body
The primary mechanism of nattokinase is fibrinolysis — the direct breakdown of fibrin, the protein mesh that forms the structural basis of blood clots. Unlike many pharmaceutical blood thinners that prevent clot formation, nattokinase actually dissolves existing fibrin [1].
A clinical trial with 45 participants demonstrated that nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII — three key clotting factors — by 7-20% after two months of supplementation at 4,000 FU daily [4]. Fibrinolytic activity peaks between 2 and 8 hours after oral intake.
What makes nattokinase notable compared to pharmaceutical fibrinolytics like tPA (tissue plasminogen activator) is its safety margin — research indicates approximately a 3x lower hemorrhagic risk [5].
Natto vs. Nattokinase Supplements
An important distinction: natto as a whole food contains nattokinase plus vitamin K2 (MK-7), isoflavones, and other bioactive compounds. Nattokinase supplements typically isolate the enzyme, and many remove vitamin K2 entirely (labeled as "vitamin K-free" or "NSK-SD"). This matters for women because natto's vitamin K2 content is central to its bone health benefits — something a K2-free nattokinase supplement won't provide.
Heart Health and Blood Pressure: Strong Evidence
Cardiovascular disease is the leading cause of death in women, yet it often develops differently than in men. After menopause, the protective effects of estrogen decline, leading to accelerated arterial stiffness, changes in lipid profiles, and increased clotting risk. This context makes the nattokinase research particularly relevant.
Blood Pressure Reduction
A landmark randomized, double-blind, placebo-controlled trial enrolled 86 participants with untreated pre-hypertension or stage 1 hypertension. Those receiving 2,000 FU of nattokinase daily for 8 weeks showed a reduction in systolic blood pressure of 5.55 mmHg and diastolic blood pressure of 2.84 mmHg compared to placebo. The study also demonstrated suppression of renin activity [3].
A separate randomized trial found a compelling sex-specific result: among women taking nattokinase, there was a 26% reduction in von Willebrand factor (vWF) — a protein linked to blood clotting and cardiovascular risk. This reduction was observed only in the female group, not in males, suggesting nattokinase may engage different cardiovascular mechanisms in women, potentially related to estrogen's complex effects on vascular function [2].
A systematic review and meta-analysis of randomized controlled trials confirmed these blood pressure benefits, noting that approximately 62% of participants across the included studies were female [5].
Cholesterol and Lipid Management
A large clinical study following 1,062 participants (571 women and 491 men) found that nattokinase effectively managed atherosclerosis progression and hyperlipidemia. Both total cholesterol and LDL cholesterol decreased, with changes in female participants described as marginally better than in males [7].
This aligns with the broader understanding that dyslipidemia prevalence in women rises sharply after menopause, making lipid-lowering interventions increasingly important during this life stage [27].
Blood Clot Prevention
Real-world safety data from 153 patients with vascular diseases — 60.1% of whom were female — showed that nattokinase supplementation improved symptoms in conditions like phlebitis and venous insufficiency without new vascular events or drug interactions [8]. A comprehensive review of nattokinase as an oral antithrombotic agent, drawing on over 260 citations, describes it as a promising alternative in cardiovascular disease prevention and treatment [6].
For women on hormonal contraceptives — who face elevated deep vein thrombosis (DVT) risk — nattokinase's antithrombotic properties are theoretically relevant. However, no clinical trials have specifically studied nattokinase for contraceptive-related DVT prevention, and it should never be used as a substitute for prescribed anticoagulants.
Bone Health and Osteoporosis Support: Moderate Evidence
Among the most underappreciated nattokinase benefits for women is the bone health connection — and this is where Japanese research offers insights that international sources almost entirely miss. While nattokinase itself is not directly linked to bone health, natto — the food from which nattokinase is derived — is the world's richest dietary source of vitamin K2 in the MK-7 form, providing approximately 350 μg per serving.
Why Vitamin K2 (MK-7) Matters for Women's Bones
Vitamin K2 activates osteocalcin, a bone matrix protein essential for mineralization. Through γ-carboxylation, MK-7 helps osteocalcin bind calcium and incorporate it into bone structure rather than allowing it to accumulate in arteries. This dual benefit — supporting bone density while protecting vascular health — is particularly relevant for postmenopausal women [13].
In Japan, vitamin K2 in the MK-4 form (at 45 mg/day) is an approved pharmaceutical treatment for osteoporosis — a regulatory decision not widely known outside of Japan.
What Japanese Epidemiological Studies Show
Japanese researchers have produced compelling data on natto consumption and bone health that rarely appears in English-language nattokinase reviews:
A study published in The Journal of Nutrition found that natto intake is inversely associated with osteoporotic fracture risk in postmenopausal Japanese women. Women who consumed natto regularly had significantly lower rates of hip fractures [9].
Two J-STAGE studies found that habitual dietary intake of natto is associated with bone mineral density in both premenopausal and postmenopausal women, with natto promoting bone formation markers [10][11].
A meta-analysis of Japanese evidence confirmed that habitual natto intake elevates serum MK-7 levels, enhances osteocalcin carboxylation, and supports bone density [12].
Perhaps most striking: geographic mapping across Japan reveals that regions with higher natto consumption have lower rates of hip fractures — a population-level correlation that reinforces the individual-level study findings [15].
The Important Caveat
A critical distinction: most nattokinase supplements on the international market remove vitamin K2 during processing (marketed as "vitamin K-free" for safety with blood thinner medications). If you're taking nattokinase specifically for bone health benefits, you may need either a K2-inclusive formulation or a separate MK-7 supplement. A randomized trial in Norwegian postmenopausal women found that natto capsules (containing K2) for one year did not significantly affect bone loss, suggesting that longer intervention periods may be needed — the positive Japanese data comes from habitual, long-term consumption [14].
Cognitive Health and Brain Function: Moderate Evidence
Women face a higher lifetime risk of Alzheimer's disease than men, and cognitive decline often accelerates after menopause. Nattokinase's ability to improve cerebral blood flow makes it a subject of growing interest.
A randomized controlled trial enrolled 120 patients with asymptomatic intracranial or carotid artery stenosis. After 6 months of nattokinase supplementation at 8,000 FU daily, the enzyme did not improve overall cognition scores. However, it did produce a statistically significant improvement in visuospatial function (intergroup difference: 0.350, P=0.024), suggesting selective neuroprotective effects [18].
Animal studies provide additional mechanistic insight. Nattokinase has been shown to reduce cerebral infarct size and arterial thickening, and to promote post-stroke neurogenesis through increased circulating irisin — a protein linked to brain repair [20]. Preclinical evidence also suggests nattokinase may protect against blood-brain barrier dysfunction in neurodegenerative disease models, reducing neuroinflammation [19].
Preliminary laboratory studies suggest nattokinase can degrade amyloid-beta plaques — the protein aggregates implicated in Alzheimer's disease — via its fibrinolytic activity. However, this has not been confirmed in human clinical trials and remains an area of active investigation.
Skin, Circulation, and Metabolic Health: Emerging Evidence
Microcirculation and Skin Health
A double-blind, placebo-controlled crossover study from Tokyo Metropolitan University found that a single dose of oral nattokinase accelerated skin temperature recovery after cold water immersion. This research is particularly relevant for women experiencing "冷え性" (cold sensitivity), a condition disproportionately affecting women and commonly studied in Japanese health research [21].
No clinical studies directly evaluate nattokinase's effects on skin aging, wrinkles, or complexion. The theoretical basis — that improved microcirculation enhances nutrient delivery to skin — is reasonable but unsubstantiated by controlled trials. Be cautious of marketing claims in this area.
Metabolic Health
A small randomized controlled trial with 17 women with obesity and diabetes found that 2,000 FU nattokinase daily for three months improved metabolic markers including HbA1c, fasting insulin, glucose levels, and insulin resistance (HOMA score), regardless of weight changes [22]. In a separate observation, 42 women with lipedema who supplemented with nattokinase reported decreased clothing size and improved fat distribution over 4 months to over a year.
These findings are encouraging but preliminary. The sample sizes are small, and larger randomized controlled trials are needed before drawing firm conclusions about nattokinase's metabolic benefits.
Hormonal Health and Menstrual Wellness: Preliminary Evidence
This is an area where honesty is important: there are essentially no clinical studies directly evaluating nattokinase's impact on menstrual health, cycle regularity, or hormonal balance.
The theoretical consideration is that nattokinase's fibrinolytic action — which breaks down clots — could affect menstrual clotting patterns. This means it could potentially increase menstrual flow in some women. One hypertension trial that included female participants did not report menstrual-related adverse effects, but the study was not designed to track this outcome [3].
Japanese health sources note that natto (the whole food, not isolated nattokinase) may support intestinal health and hormonal balance through its fermented food properties, isoflavones, and nutrient profile. A Japanese study even examined the mood-improving effects of black soybean natto in women around menopause [17]. However, these benefits relate to natto as a complete food, not to nattokinase supplements specifically.
For women considering nattokinase during perimenopause or menopause, the cardiovascular benefits described above may be the most clinically relevant, since this is precisely when cardiovascular risk accelerates.
How to Take Nattokinase: Dosage and Timing for Women
Recommended Dosage
When evaluating the nattokinase benefits for women most relevant to your goals, dosage matters. Based on the clinical trial evidence reviewed, dosage recommendations are:
| Purpose | Dosage | Duration | Evidence Level |
|---|---|---|---|
| Blood pressure support | 2,000 FU daily | 8+ weeks | Strong (multiple RCTs) |
| Blood clotting factor reduction | 4,000 FU daily | 8 weeks | Strong (clinical trial) |
| Metabolic health support | 2,000 FU daily | 3+ months | Emerging (small trial) |
| Cognitive support | 8,000 FU daily | 6 months | Moderate (single RCT) |
FU stands for fibrinolytic units, the standard measure of nattokinase potency. A typical supplement provides 2,000 FU per capsule (approximately 100 mg of nattokinase).
Timing and Practical Guidance
Many practitioners suggest taking nattokinase in the evening or at bedtime. The rationale is that blood clot risk is highest during sleep and early morning hours, and nattokinase's fibrinolytic activity peaks 2-8 hours after ingestion.
Nattokinase can be taken with or without food. Blood pressure improvements typically appear within 4-8 weeks of consistent supplementation.
For bone health benefits from vitamin K2 (MK-7), dietary natto or a supplement that includes MK-7 is necessary — standard nattokinase isolates typically remove vitamin K.
Safety Considerations for Women
Overall Safety Profile
Nattokinase is considered likely safe when consumed in food amounts and possibly safe as a supplement at typical doses (2,000-4,000 FU daily) for up to 3 years. Toxicology studies confirm low toxicity, no mutagenic effects, and safety at doses up to 1,000 mg/kg/day in rodents — roughly 100 times typical human doses [5].
A real-world observational study of 153 vascular disease patients (60.1% female) reported no serious adverse events during nattokinase supplementation [8].
Common Side Effects
- Mild gastrointestinal discomfort (infrequent)
- Potential for increased bruising
- Possible hypotension when combined with antihypertensive medications
Who Should Avoid Nattokinase
| Group | Reason |
|---|---|
| Women on blood thinners (warfarin, heparin, aspirin) | Enhanced bleeding risk — nattokinase adds fibrinolytic activity |
| Pre-surgical patients | Stop at least 2 weeks before any scheduled surgery |
| Women with bleeding disorders | Nattokinase's anticoagulant effects could worsen bleeding |
| Soy allergy sufferers | Nattokinase is derived from soybeans |
Pregnancy and Breastfeeding
Nattokinase is not recommended during pregnancy or breastfeeding due to insufficient safety data. While no adverse fetal or neonatal outcomes have been reported, clinical trials have not been conducted in pregnant or nursing populations. The precautionary principle applies [25].
Hormonal Contraceptives and HRT
No studies specifically evaluate interactions between nattokinase and hormonal contraceptives or hormone replacement therapy. Since both nattokinase and estrogen-containing medications affect coagulation, combining them warrants medical supervision. Discuss with your healthcare provider, particularly if you have additional risk factors for blood clots [24].
Nattokinase is not a substitute for prescribed anticoagulant medications. It should complement — never replace — medical treatment for cardiovascular conditions.
What Japanese Research Adds to the Picture
The Whole Food vs. Isolated Enzyme Gap
When you look at the full picture of nattokinase benefits for women, the gap between international and Japanese research becomes clear. Most international nattokinase research isolates the enzyme and studies it as a single compound. Japanese researchers, by contrast, frequently study natto as a whole food — and the results differ meaningfully. Natto provides nattokinase, vitamin K2 (MK-7), soy isoflavones, polyglutamic acid, and beneficial bacteria simultaneously. The bone health data, for instance, comes almost entirely from whole natto or K2-inclusive studies, not from K2-stripped nattokinase supplements.
Why this matters: If your goal includes bone health alongside cardiovascular support, a natto-based approach or a K2-inclusive nattokinase supplement may offer benefits that a standard K2-free supplement cannot.
A Thousand Years of Dietary Data
Japan has population-level data on natto consumption spanning decades that simply doesn't exist anywhere else. The geographic mapping of natto consumption against fracture rates, the JPHC cohort studies linking natto intake to cardiovascular outcomes, and the regional dietary surveys all provide a type of evidence that controlled trials alone cannot. These epidemiological datasets — covering hundreds of thousands of participants — add a dimension of long-term safety and efficacy evidence that supplement-focused international research lacks [16].
Why this matters: Long-term dietary pattern data suggests that regular natto consumption is associated with measurable health benefits in women, offering reassurance that extends beyond typical clinical trial durations.
Functional Food Regulation Creates Different Standards
In Japan, nattokinase has been approved as a 機能性表示食品 (food with functional claims) ingredient, specifically for supporting blood pressure in individuals with normal-high levels. This regulatory framework requires manufacturers to submit scientific evidence for each claimed benefit — a step beyond the supplement industry's self-regulation common in many countries. Kobayashi Pharmaceutical, for example, markets a nattokinase product (さらさら粒) with MHLW-approved functional claims at 3.97 mg (2,000 FU) daily [26].
Why this matters: Japanese functional food regulation provides an additional layer of evidence review that can help consumers identify products with substantiated claims.
Cold Sensitivity Research You Won't Find in English
Japanese health research includes a condition called "冷え性" (cold constitution or cold sensitivity) — a circulatory condition disproportionately affecting women. A controlled study at Tokyo Metropolitan University found nattokinase improved skin temperature recovery after cold exposure, suggesting benefits for peripheral circulation. This type of research reflects a broader Japanese health perspective that considers circulatory well-being differently than many international approaches.
Why this matters: For women who experience chronically cold hands and feet, nattokinase's circulation-supporting properties may address a concern that conventional supplements rarely target.
Our Recommendation
Noguchi Nattokinase HQ
Why We Selected This: Noguchi is a trusted Japanese supplement manufacturer with a legacy of producing high-quality nattokinase formulations. We selected this product for customers seeking premium Japanese nattokinase with verified potency and purity standards.
This formulation delivers nattokinase at a concentration designed for cardiovascular support. As a Japanese-manufactured product, it meets the quality standards of Japan's supplement manufacturing framework — offering traceability and consistency that align with the clinical evidence discussed throughout this guide.
For women focused on cardiovascular health and circulation support, this is our primary recommendation. If you're also interested in bone health benefits, consider pairing it with a separate vitamin K2 (MK-7) supplement or incorporating natto into your diet directly, since most nattokinase supplements remove vitamin K2 during processing.
We also carry two additional nattokinase formulations for different needs:
Japanese Nattokinase 4000 — A higher-potency option at 4,000 FU for those seeking stronger fibrinolytic support, aligning with the dosage used in the clotting factor reduction study referenced above.
View Japanese Nattokinase 4000 →
Nattokinase EX — Formulated specifically for cardiovascular support with complementary ingredients.
Conclusion
The evidence-based nattokinase benefits for women center on cardiovascular health, with the strongest data supporting blood pressure reduction, fibrinolytic activity, and lipid management — benefits that become increasingly relevant as women enter perimenopause and beyond. The sex-specific finding of von Willebrand factor reduction in women adds a dimension that gender-neutral guides typically overlook.
Japanese research enriches the picture substantially, particularly around bone health through natto's vitamin K2 content and the population-level data linking natto consumption to lower fracture rates. For emerging areas like cognitive health, metabolic support, and skin circulation, the evidence is promising but not yet definitive.
The key insight from our review: choosing between a nattokinase isolate and a whole natto-based supplement matters more than most guides acknowledge — especially for women interested in both cardiovascular and bone health benefits. As with any supplement, consult your healthcare provider, particularly if you're on blood thinners, hormonal medications, or are pregnant or breastfeeding.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any supplement regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease
- Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor
- Effects of nattokinase on blood pressure: a randomized, controlled trial
- Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects
- Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis
- Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases
- Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: 1,062 participants
- Data recorded in real life support the safety of nattokinase in patients with vascular diseases
- Natto intake is inversely associated with osteoporotic fracture risk in postmenopausal Japanese women
- Usual dietary intake of fermented soybeans (Natto) is associated with bone mineral density in premenopausal women
- Promotion of bone formation by fermented soybean (Natto) intake in premenopausal women
- Habitual natto intake elevates serum MK-7 levels, enhances osteocalcin carboxylation, and supports bone density
- Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation
- Vitamin K2 supplementation does not influence bone loss in early menopausal women
- 納豆摂取と骨折リスク (Natto intake and fracture risk)
- 納豆の発酵に伴う成分変化と健康機能 (Compositional changes and health functions during natto fermentation)
- 黒豆納豆の気分改善効果 (Mood improvement effects of black soybean natto in perimenopausal women)
- RCT of nattokinase on cognitive function in patients with intracranial stenosis
- Nattokinase neuroprotective effects on blood-brain barrier dysfunction


